Atlas Trials

Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes

Clinical trial NCT03580967 · WITHDRAWN

Trial details

NCT number
NCT03580967
Sponsor
Todd Doyle
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type2 DiabetesMajor Depressive Disorder
Start date
2019-07-01
Primary completion
2021-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.